The Trump administration decided to put the pilot on hold until at least 2027.

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The Centers for Medicare and Medicaid Services (CMS) is rolling out a program this summer that will provide more affordable ...

The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...

The Centers for Medicare & Medicaid Services (CMS) has postponed its BALANCE program, intended to integrate obesity drugs into Medicare Part D, to January 2027 after failing to secure sufficient ...

Louisville companies Cornbread Hemp and Alliant Purchasing are part of a new Medicare pilot program for cannabis products.

Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage ...

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

A federal pilot program that uses artificial intelligence to crack down on "wasteful" medical procedures is slowing and denying health care for senior citizens in Washington ...

Dr. Mehmet Oz announced an initiative, requiring all 50 states to audit their Medicaid provider networks in a move marking a ...